Archives
Please, enter cell line, author or any other phrase or word you would like to search for.
Leading life science tools company enters technology assessment agreement with PHI
A major publicly traded life science tools company has entered a technology assessment agreement with Phase Holographic Imaging (PHI). The purpose of the agreement is to assess PHI’s Holo¬Monitor technology for cell biology applications, primarily within immuno-oncology.
PHI and BioSpherix expand marketing partnership after scientific evaluation
In June 2018, Phase Holographic Imaging (PHI) and BioSpherix Medical entered a collaboration agreement, aiming to co-market the companies’ complementary product lines. BioSpherix develops and market advanced hermetically sealed cell incubators for the control and optimization of cell culture environments.
Cancer researchers use HoloMonitor to track skin cancer cells
Scientists at the Holographic Imaging Cytometry Center of Excellence at University of California, San Francisco, study how normal skin cells transform into aggressive skin cancer. HoloMonitor M4 plays an important role in their research.
Cell Tracking for Early Skin Cancer Detection
Melanoma, the most dangerous form of skin cancer, is increasing. In the US, melanoma is one of the most common cancers among young adults. However, if the disease is caught early, then it can be cured. A research team, led by Dr Robert Judson-Torres, is tracking single cells when studying melanoma at an early stage.
Replacing animal experiments with advanced cell culture studies
Tests on animals are routinely used in many research areas, including pre-clinical drug development and testing of chemicals and cosmetics. Today, there is a growing interest in developing alternatives to research methods that involves living animals, and also to replace animal derived components used in different kind of products.
New Publication shows Advantages of using HoloMonitor® for Cell Movement Assessment
Understanding of cell movements is essential in many aspects of cell biology research, and crucial not least in cancer research.
Interim Report for the second quarter
For the first time, sales during the past 12 months reached 5 MSEK. Since our previous report, much effort has gone into implementing the ambitious market expansion made possible by the capital acquisition this summer.
Lund University and PHI partner to develop novel 3D cell culturing methods for immunotherapy research
Based on PHI’s current HoloMonitor technology, the Department of Immunotechnology at Lund University and Phase Holographic Imaging (PHI) recently agreed to jointly develop novel 3-dimensional cell culturing methods to meet the urgent need for such methods.
A study of cancer cells by digital holographic imaging, fluorescence and a combination thereof
Digital holographic imaging is a label-free, non-toxic quantitative method that can be used for single cell analysis for a long time period. Sofia Kamlund, PhD, Lund University and Phase Holographic Imaging, has used this method in her thesis Not all those who wander are lost – A Study of Cancer Cells by Digital Holographic Imaging, Fluorescence and a combination there of. The technique allows the researcher to follow changes over time and evaluate cell response on living cells.
